---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-441634"
form_type: "8-K"
ticker: "NMRA"
cik: "0001885522"
company_name: "Neumora Therapeutics, Inc."
filed_at: "2026-10-30T20:05:16+00:00"
generated_at: "2026-10-30T20:06:12.275818+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Neumora gets Nasdaq bid-price notice; 180 days to regain $1.00 compliance by April 26, 2027

## Summary
- Nasdaq notified Neumora on October 26, 2026 that its common stock is below the $1.00 minimum bid price under Listing Rule 5450(a)(1).
- Company has until April 26, 2027; shares must close at or above $1.00 for at least 10 consecutive business days to cure.
- If not cured, Neumora could apply to transfer to the Nasdaq Capital Market for additional time, subject to other listing standards and a fee.
- Neumora said it will monitor its bid price and consider options including a reverse stock split; no assurance of compliance was given.

## SEC filing metadata
- accession: 0001193125-26-441634
- form_type: 8-K
- ticker: NMRA
- cik: 0001885522
- company_name: Neumora Therapeutics, Inc.
- filed_at: 2026-10-30T20:05:16+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1885522/000119312526441634/0001193125-26-441634-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1885522/000119312526441634/d128962d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-441634
- JSON: https://secwatch.observer/filing/0001193125-26-441634.json
- Plain text: https://secwatch.observer/filing/0001193125-26-441634.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.